Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study
Kochhar, Gursimran , Crosby, Sheena , Kinnucan, Jami , Picco, Michael F., Farraye, Francis A. , Petrov, Jessica C , Desai, Aakash A., Kinnucan, Jami A., Farraye, Francis A , Desai, Aakash , Hashash, Jana G.

Inflammatory Bowel Diseases | July 13, 2024 | Volume: 31 | Issue: 5 | Pages: 1237-1247

10.1093/ibd/izae147 | PMID 39001616 Get It

Abstract Background Metformin exerts anti-inflammatory properties through a positive effect on oxidative stress, gut barrier integrity, and the gut microbiota. Our aim was to evaluate the influence of metformin on inflammatory bowel disease (IBD) outcomes in patients with type 2 diabetes mellitus (T2DM). Methods We conducted a retrospective cohort study using the TriNetX database in patients with IBD and T2DM who initiated metformin vs oral hypoglycemics or insulin (control cohort) between August 31, 2002, and August 31, 2022. One-to-one propensity score matching was performed. Primary outcomes were need for intravenous (IV) steroid use or IBD-related surgery within 1, 2, and 3 years after metformin initiation. Results Our cohorts included 1323 patients with ulcerative colitis (UC) (mean age 58.7 ± 12.2 years, 50.1% female, 77.3% White) and 1278 patients with Crohn’s disease (CD) (mean age 56.3 ± 12.6 years, 58.2% female, 76.5% White). At 1 year, patients with UC and CD were less likely to require IV steroids (UC: adjusted odds ratio [aOR], 0.45; 95% confidence interval [CI], 0.34-0.59; P < .01; CD: aOR, 0.67; 95% CI, 0.53-0.85; P < .01). The decreased need for IV steroids persisted in all metformin groups at 2 and 3 years. Patients with CD were at a lower risk for IBD-related surgery at year 1 (aOR, 0.5; 95% CI, 0.31-0.81; P < .01), and this finding persisted at 3 years (aOR, 0.62; 95% CI, 0.43-0.89; P < .01). Metformin did not affect risk for surgery in patients with UC. Conclusions Patients with IBD and T2DM on metformin had a decreased likelihood of worse IBD outcomes.
The right educational environment: Oral tolerance in early life
Cheifetz, Talia Raitt, Knoop, Kathryn A. , Cheifetz, Talia R, Knoop, Kathryn A

Immunological Reviews | July 13, 2024 | Volume: 326 | Issue: 1 | Pages: 17-34

10.1111/imr.13366 | PMID 39001685 Get It

Summary Oral tolerance promotes the suppression of immune responses to innocuous antigen and is primarily mediated by regulatory T cell (Tregs). The development of oral tolerance begins in early life during a “window of tolerance,” which occurs around weaning and is mediated by components in breastmilk. Herein, we review the factors dictating this window and how Tregs are uniquely educated in early life. In early life, the translocation of luminal antigen for Treg induction is primarily dictated by goblet cell‐associated antigen passages (GAPs). GAPs in the colon are negatively regulated by maternally‐derived epidermal growth factor and the microbiota, restricting GAP formation to the “periweaning” period (postnatal day 11–21 in mice, 4–6 months in humans). The induction of solid food also promotes the diversification of the bacteria such that bacterially‐derived metabolites known to promote Tregs—short‐chain fatty acids, tryptophan metabolites, and bile acids—peak during the periweaning phase. Further, breastmilk immunoglobulins—IgA and IgG—regulate both microbial diversity and the interaction of microbes with the epithelium, further controlling which antigens are presented to T cells. Overall, these elements work in conjunction to induce a long‐lived population of Tregs, around weaning, that are crucial for maintaining homeostasis in adults.
Atrial Tachyarrhythmia in Arrhythmogenic Right Ventricular Cardiomyopathy: A Case Report
Sharma, Shriya , Giri, Ganesh , Khadka, Sadiksha , Goswami, Rohan

No container title available | July 13, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.172084840.07301692/v1 Get It

Commentary on “Efficacy of 0.25% Lidocaine Versus 0.5% Lidocaine in Dermatologic Surgery: A Double-Blind, Randomized Controlled Trial”
Barbosa, Naiara S. , Degesys, Catherine A.

Dermatologic Surgery | July 12, 2024 | Volume: 51 | Issue: 1 | Pages: 34-35

10.1097/dss.0000000000004331 | PMID 39665469 Get It

In vitro evaluation of flow diverter performance using a human fibrinogen–based flow model
Bilgin, Cem , Kallmes, David F. , Kadirvel, Ramanathan , Bayraktar, Esref Alperen , Oliver, Alexander A , Li, Jiahui , Cebral, Juan R.

Journal of Neurosurgery | July 12, 2024 | Volume: 142 | Issue: 1 | Pages: 154-161

10.3171/2024.4.jns232567 | PMID 38996402 Get It

OBJECTIVE Fibrin deposition represents a key step in aneurysm occlusion, promoting endothelization of implants and connective tissue organization as part of the aneurysm-healing mechanism. In this study, the authors introduce a novel in vitro testing platform for flow diverters based on human fibrinogen. METHODS A flow diverter was deployed in 4 different glass models. The glass models had the same internal parent artery (4 mm) and aneurysm (8 mm) diameters with varying parent artery angulations (paraophthalmic, sidewall, bifurcation, and slightly curved models). The neck size and area were 4 mm and 25 mm 2 , respectively. Human fibrinogen (330 mg/dl) was circulated within the glass models at varying flow rates (0, 3, 4, and 5 ml/sec) with or without heparin, calcium chloride, and thrombin for as long as 6 hours or until complete fibrin coverage of the flow diverter’s neck was achieved. Aneurysm neck coverage was defined as macroscopic fibrin deposition occluding the flow diverters’ pores. Flow characteristics after flow diverter deployment were assessed with computational fluid dynamics analysis. The effects of flow rates, heparin, calcium chloride, and thrombin on fibrin deposition rates were tested using 1-way ANOVA and the Tukey test. RESULTS A total of 84 replicates were performed. Human fibrin did not accumulate on the flow diverter stents under static conditions. The fibrin deposition rate on the aneurysm neck was significantly greater with the 5 ml/sec flow rate as compared to 3 ml/sec for all models. The paraophthalmic model had the highest inflow velocity of 48.7 cm/sec. The bifurcation model had the highest maximum shear stress (SS) and maximum normalized shear stress values at the device cells at 843.3 dyne/cm 2 and 35.1 SS/SS inflow , respectively. The fibrin deposition rates of the paraophthalmic and bifurcation models were significantly higher than those of sidewall and slightly curved models for all additive or flow rate comparisons (p = 0.001 for all comparisons). The incorporation of thrombin significantly increased the fibrin deposition rates across all models (p = 0.001 for all models). CONCLUSIONS Rates of fibrin deposition varied widely across different configurations and additive conditions in this novel in vitro model system. Fibrin accumulation started at the aneurysm inflow zone where flow velocity and shear stress were the highest. The primary factors influencing fibrin deposition included flow velocities, shear stress, and the addition of thrombin at a physiological concentration. Further research is needed to test the clinical utility of fibrinogen-based models for patient-specific aneurysms.
Risk prediction for clonal cytopenia: multicenter real-world evidence
Xie, Zhuoer , Komrokji, Rami S. , Al‐Ali, Najla, Regelson, Alexandra, Geyer, Susan, Patel, Anand , Saygin, Caner , Zeidan, Amer M. , Mendez, Lourdes , Coombs, Catherine C. , Madanat, Yazan F. , Chung, Stephen S. , Badar, Talha , Foran, James M. , Tsai, Charlton , Amanam, Idoroenyi , Deeg, H. Joachim , Adès, Lionel, Osman, Afaf E.G. , Dinner, Shira, Chandhok, Namrata S. , Soong, Deborah, Brunner, Andrew M. , Ferrari, Jacqueline, Pozzi, Sara , Padron, Eric , Patnaik, Mrinal M. , Al‐Kali, Aref , Adès, Lionel , Komrokji, Rami S , Mendez, Lourdes , Zeidner, Joshua F , Madanat, Yazan , Badar, Talha , Griffiths, Elizabeth A. , Al Malki, Monzr M , Lai, Catherine , Arana Yi, Cecilia , Osman, Afaf E G , Abaza, Yasmin , Taylor, Justin , Chandhok, Namrata , Carraway, Hetty E. , Elena, Chiara , Gallì, Anna , Patnaik, Mrinal , Malcovati, Luca , Savona, Michael R , Al-Kali, Aref , Patel, Anand , Xie, Zhuoer , Zeidan, Amer M , Bewersdorf, Jan Philipp , Kishtagari, Ashwin , Zeidner, Joshua F. , Desai, Pinkal , Malki, Monzr M. Al , Lai, Catherine , Yi, Cecilia Arana , Abaza, Yasmin , Singh, Abhay , Malcovati, Luca , Savona, Michael R.

Blood | July 12, 2024 | Volume: 144 | Issue: 19 | Pages: 2033-2044

10.1182/blood.2024024756 | PMID 38996210 Get It

Abstract Clonal cytopenia of undetermined significance (CCUS) represents a distinct disease entity characterized by myeloid-related somatic mutations with a variant allele fraction of ≥2% in individuals with unexplained cytopenia(s) but without a myeloid neoplasm (MN). Notably, CCUS carries a risk of progressing to MN, particularly in cases featuring high-risk mutations. Understanding CCUS requires dedicated studies to elucidate its risk factors and natural history. Our analysis of 357 patients with CCUS investigated the interplay between clonality, cytopenia, and prognosis. Multivariate analysis identified 3 key adverse prognostic factors: the presence of splicing mutation(s) (score = 2 points), platelet count of <100 × 109/L (score = 2.5), and ≥2 mutations (score = 3). Variable scores were based on the coefficients from the Cox proportional hazards model. This led to the development of the clonal cytopenia risk score (CCRS), which stratified patients into low- (score of <2.5 points), intermediate- (score of 2.5 to <5), and high-risk (score of ≥5) groups. The CCRS effectively predicted 2-year cumulative incidence of MN for low- (6.4%), intermediate- (14.1%), and high-risk (37.2%) groups, respectively, by the Gray test (P < .0001). We further validated the CCRS by applying it to an independent CCUS cohort of 104 patients, demonstrating a c-index of 0.64 (P = .005) in stratifying the cumulative incidence of MN. Our study underscores the importance of integrating clinical and molecular data to assess the risk of CCUS progression, making the CCRS a valuable tool that is practical and easily calculable. These findings are clinically relevant, shaping the management strategies for CCUS and informing future clinical trial designs.
Triceps-to-Biceps Tendon Transfer Technique for Restoration of Elbow Flexion in Adult Brachial Plexus Injury
Weber, Morgan B. , Townsley, Sarah, Spinner, Robert J. , Bishop, Allen T. , Shin, Alexander Y.

Techniques in Hand & Upper Extremity Surgery | July 12, 2024 | Volume: 28 | Issue: 4 | Pages: 214-223

10.1097/bth.0000000000000491 | PMID 38995200 Get It

Restoration of elbow flexion is a priority in treating adult traumatic brachial plexus injuries. A tendon transfer is an ideal option for patients not candidates for reconstructive nerve surgery or free-functioning muscle transfer. For patients with a partial brachial plexus injury or a pan plexus injury with adequate recovered triceps function and loss of elbow flexion, a triceps-to-biceps tendon transfer is a nonmicrosurgical option to restore elbow flexion. The technique of triceps-to-biceps transfer in which the complete triceps tendon is transferred laterally, secured lateral to the radial tuberosity, and reinforced with suture to the biceps tendon is described.
Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females
Cooper, Isabella D. , Kyriakidou, Yvoni , Petagine, Lucy , Edwards, Kurtis , Soto-Mota, Adrián , Brookler, Kenneth H. , Elliott, Bradley , Brookler, Kenneth , Elliott, Bradley T

Biomedicines | July 12, 2024 | Volume: 12 | Issue: 7 | Pages: 1553

10.3390/biomedicines12071553 | PMID 39062126 Get It

Metabolic dysfunctions are among the best documented hallmarks of ageing. Cardiovascular disease, Alzheimer’s disease, cancer, type 2 diabetes mellitus, metabolic-dysfunction-associated steatosis liver disease, and fragility fractures are diseases of hyperinsulinaemia that reduce life and healthspan. We studied the effect of suppressing ketosis in 10 lean (BMI 20.5 kg/m2 ± 1.4), metabolically healthy, pre-menopausal women (age 32.3 ± 8.9 years) maintaining nutritional ketosis (NK) for an average of 3.9 years (± 2.3) who underwent three 21-day phases: nutritional ketosis (NK; P1), suppressed ketosis (SuK; P2), and returned to NK (P3). Ketosis suppression significantly increased insulin, 1.83-fold (p = 0.0006); glucose, 1.17-fold (p = 0.0088); homeostasis model assessment for insulin resistance (HOMA-IR), 2.13-fold (p = 0.0008); leptin, 3.35-fold (p = 0.0010); total osteocalcin, 1.63-fold (p = 0.0138); and uncarboxylated osteocalcin, 1.98-fold (p = 0.0417) and significantly decreased beta-hydroxybutyrate, 13.50-fold (p = 0.0012) and glucagon-like peptide-1 (GLP-1), 2.40-fold (p = 0.0209). Sustained NK showed no adverse health effects and may mitigate hyperinsulinemia. All biomarkers returned to basal P1 levels after removing the intervention for SuK, indicating that metabolic flexibility was maintained with long-term euketonaemia.
Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic Niche
Suman, Shankar , Nevala, Wendy K. , Leontovich, Alexey A. , Ward, Caitlin , Jakub, James W. , Kim, Yohan, Geng, Liyi, Stueven, Noah A. , Atherton, Chathu L., Moore, Raymond M. , Schimke, Jill M. , Lucien, Fabrice , McLaughlin, Sarah A., Lucien, Fabrice , Jakub, James W , Moore, Raymond , Markovic, Svetomir N.

Biomolecules | July 12, 2024 | Volume: 14 | Issue: 7 | Pages: 837

10.3390/biom14070837 | PMID 39062552 Get It

CD36 expression in both immune and non-immune cells is known to be directly involved in cancer metastasis. Extracellular vesicles (EVs) secreted by malignant melanocytes play a vital role in developing tumor-promoting microenvironments, but it is unclear whether this is mediated through CD36. To understand the role of CD36 in melanoma, we first analyzed the SKCM dataset for clinical prognosis, evaluated the percentage of CD36 in lymphatic fluid-derived EVs (LEVs), and tested whether melanoma-derived EVs increase CD36 expression and induce M2-macrophage-like characteristics. Furthermore, we performed a multiplex immunofluorescence (MxIF) imaging analysis to evaluate the CD36 expression and its colocalization with various other cells in the lymph node (LN) of patients and control subjects. Our findings show that cutaneous melanoma patients have a worse clinical prognosis with high CD36 levels, and a higher percentage of CD36 in total LEVs were found at baseline in melanoma patients compared to control. We also found that monocytic and endothelial cells treated with melanoma EVs expressed more CD36 than untreated cells. Furthermore, melanoma-derived EVs can regulate immunosuppressive macrophage-like characteristics by upregulating CD36. The spatial imaging data show that cells in tumor-involved sentinel LNs exhibit a higher probability of CD36 expression than cells from control LNs, but this was not statistically significant. Conclusively, our findings demonstrated that CD36 plays a vital role in controlling the immunosuppressive microenvironment in the LN, which can promote the formation of a protumorigenic niche.